Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection

被引:5
|
作者
Price, Jennifer C. [1 ]
Seaberg, Eric C. [2 ]
Phair, John P. [3 ]
Witt, Mallory D. [4 ]
Koletar, Susan L. [5 ]
Thio, Chloe L. [6 ]
机构
[1] Univ Calif San Francisco, Dept Med, Div Gastroenterol & Hepatol, 513 Parnassus Ave,S-357, San Francisco, CA 94143 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Northwestern Univ, Dept Med, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles Biomed Res Inst,Harbor UCLA, Torrance, CA USA
[5] Ohio State Univ, Dept Med, Div Infect Dis, Columbus, OH 43210 USA
[6] Johns Hopkins Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
HIV; HBV; HCV; antiviral therapy; liver; hepatitis; APRI; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; MULTICENTER AIDS COHORT; PLATELET RATIO INDEX; FIBROSIS PROGRESSION; MONOINFECTED PATIENTS; COINFECTED PATIENTS; NONINVASIVE INDEX; HUMAN HEPATOCYTES; VIRAL-HEPATITIS;
D O I
10.1097/QAI.0000000000000981
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the impact of highly active antiretroviral therapy (HAART) on liver disease, we analyzed changes in the aspartate aminotransferase to platelet ratio index (APRI) pre-and post-HAART initiation among 441 HIV-monoinfected and 53 HIV-viral hepatitis-coinfected men. Before HAART, APRI increased 17% and 34% among the HIV-monoinfected and coinfected men, respectively. With HAART initiation, APRI decreased significantly in men who achieved HIV RNA of <500 copies per milliliter: 16% for HIV-monoinfected and 22% for coinfected men. Decreases in APRI were dependent on HIV suppression. This protective effect of HAART decreased after 2 years, particularly in the HIV-monoinfected men.
引用
收藏
页码:319 / 323
页数:5
相关论文
共 50 条
  • [1] Monitoring of highly active antiretroviral therapy in HIV infection
    Walker, A. Sarah
    Gibb, Diana M.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2011, 24 (01) : 27 - 33
  • [2] Highly active antiretroviral therapy for HIV infection: lessons for the future
    Burger, DM
    van der Ven, AJAM
    Koopmans, PP
    NETHERLANDS JOURNAL OF MEDICINE, 2004, 62 (11): : 407 - 408
  • [3] HIV infection, highly active antiretroviral therapy and the cardiovascular system
    Barbaro, G
    CARDIOVASCULAR RESEARCH, 2003, 60 (01) : 87 - 95
  • [4] Sarcoidosis and HIV infection: Influence of highly active antiretroviral therapy
    Blanche, P
    Passeron, A
    Gombert, B
    Ginsburg, C
    Salmon, D
    Sicard, D
    BRITISH JOURNAL OF DERMATOLOGY, 1999, 140 (06) : 1185 - 1185
  • [5] Ten years of highly active antiretroviral therapy for HIV infection
    Chen, Luke F.
    Hoy, Jennifer
    Lewin, Sharon R.
    MEDICAL JOURNAL OF AUSTRALIA, 2007, 186 (03) : 146 - 151
  • [6] The neuropathology of HIV infection in the era of highly active antiretroviral therapy
    Vallat-Decouvelaere, AV
    Chrétien, F
    de la Grandmaison, GL
    Carlier, R
    Force, G
    Gray, F
    ANNALES DE PATHOLOGIE, 2003, 23 (05) : 408 - 423
  • [7] Osteoarticular complications related to HIV infection and highly active antiretroviral therapy
    Lima, Ana Lucia Lei Munhoz
    Zumiotti, Arnaldo Valdir
    Camanho, Gilberto Luis
    Benegas, Eduardo
    dos Santos, Alexandre Leme Godoy
    D'Elia, Caio Oliveira
    Oliveira, Priscila Rosalba Domingos
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (04): : 426 - 429
  • [8] Starting highly active antiretroviral therapy for HIV infection: Is it WIHS to wait?
    Schooley, RT
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (04) : 305 - 306
  • [9] Effect of highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection
    Caso, JAA
    Mingo, CS
    Tena, JG
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (16): : 1239 - 1240
  • [10] Response to highly active antiretroviral therapy according to duration of HIV infection
    Pezzotti, P
    Pappagallo, M
    Phillips, PN
    Boros, S
    Valdarchi, C
    Sinicco, A
    Zaccarelli, M
    Rezza, G
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (05) : 473 - 479